Jaikumar Duraiswamy PhD

Dr. Jaikumar Duraiswamy is a product/CMC reviewer in the Cell Therapies Branch (CTB) at Office of Tissues and Advanced Therapies in CBER/FDA. Jaikumar is responsible for regulatory review of immunotherapy- related products. He participates at several scientific and regulatory meetings, and in working groups focused on the advancement and understanding of basic immunology and immunotherapy. He has many years of academic research experience in immunology and immunotherapy for various cancers and infectious diseases. He has several publications and patents, and received several awards.